Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Acquir Immune Defic Syndr ; 63(1): 120-5, 2013 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-23334506

RESUMEN

OBJECTIVE: To compare the 2 control arms of HPTN 035 [a hydroxyethylcellulose (HEC) gel control arm and a no-gel control arm] to assess the behavioral effects associated with gel use and direct causal effects of the HEC gel on sexually transmitted infections (STIs), pregnancy, and genital safety. DESIGN: Randomized trial with 1 blinded (HEC gel) and 1 open-label (no-gel) control arms. METHODS: HIV-uninfected, sexually active women were randomized into the HEC gel arm (n = 771) and into the no-gel arm (n = 772) in 5 countries. Participants in the HEC gel arm were instructed to insert the study gel intravaginally <1 hour before each vaginal sex act. Data on sexual behavior, adherence, safety, pregnancy, and STIs were collected quarterly for 12-30 months of follow-up. RESULTS: During follow-up, mean reported condom use in the past week was significantly higher in the no-gel arm (81% versus 70%, P < 0.001). There were no significant differences, after adjusting for this differential condom use, between the 2 arms in the rates of genital safety events, pregnancy outcomes, or STIs, including HIV-1. CONCLUSIONS: In this large randomized trial, we found no significant differences between the no-gel and HEC gel arms in the rates of genital safety events, pregnancy outcomes, or STIs. These results aid interpretation of the results of previous vaginal microbicide trials that used the HEC gel as a control. The HEC gel is suitable as a control for ongoing and future vaginal microbicide studies.


Asunto(s)
Antiinfecciosos/administración & dosificación , Celulosa/análogos & derivados , Geles/administración & dosificación , Infecciones por VIH/prevención & control , Enfermedades de Transmisión Sexual/prevención & control , Vagina/efectos de los fármacos , Administración Intravaginal , Adulto , Antiinfecciosos/efectos adversos , Antiinfecciosos/farmacología , Celulosa/administración & dosificación , Celulosa/efectos adversos , Celulosa/farmacología , Femenino , Geles/efectos adversos , Geles/farmacología , Infecciones por VIH/epidemiología , VIH-1 , Humanos , Masculino , Cooperación del Paciente , Placebos/administración & dosificación , Placebos/efectos adversos , Placebos/farmacología , Embarazo , Resultado del Embarazo , Conducta Sexual , Enfermedades de Transmisión Sexual/epidemiología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA